betaine has been researched along with Alloxan Diabetes in 20 studies
glycine betaine : The amino acid betaine derived from glycine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaine is a nontoxic, chemically stable and naturally occurring molecule." | 5.48 | Betaine Supplementation Enhances Lipid Metabolism and Improves Insulin Resistance in Mice Fed a High-Fat Diet. ( Bai, L; Du, J; Gan, M; Jiang, A; Jiang, Y; Jin, L; Li, M; Li, X; Ma, J; Shen, L; Tan, Z; Tang, G; Wang, J; Xu, Y; Yang, Q; Zhang, P; Zhang, S; Zhao, X; Zhu, L, 2018) |
| "Treatment with dapagliflozin failed to rescue glycolysis." | 1.91 | Mapping the metabolic reprogramming induced by sodium-glucose cotransporter 2 inhibition. ( Abramovich, I; Agranovich, B; Ben-Haroush Schyr, R; Ben-Zvi, D; Bernal-Mizrachi, E; Cerasi, E; Gottlieb, E; Hinden, L; Kadosh, L; Kleiman, D; Kogot-Levin, A; Leibowitz, G; Mosenzon, O; Riahi, Y; Tam, J, 2023) |
| "Betaine is a nontoxic, chemically stable and naturally occurring molecule." | 1.48 | Betaine Supplementation Enhances Lipid Metabolism and Improves Insulin Resistance in Mice Fed a High-Fat Diet. ( Bai, L; Du, J; Gan, M; Jiang, A; Jiang, Y; Jin, L; Li, M; Li, X; Ma, J; Shen, L; Tan, Z; Tang, G; Wang, J; Xu, Y; Yang, Q; Zhang, P; Zhang, S; Zhao, X; Zhu, L, 2018) |
| "Betaine treatment attenuated this increase in VEGF and HIF-1α expression via suppression of diabetes-induced Akt activation in the retinas of the diabetic rats." | 1.42 | Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats. ( Kim, CJ; Kim, YG; Lee, SH; Lim, HH; Shin, MS; Yang, HJ, 2015) |
| "Betaine levels were found to be increased in the majority of diabetic mice but decreased in a few animals with severe loss of body weight and physical condition." | 1.35 | Metabolic profile changes in the testes of mice with streptozotocin-induced type 1 diabetes mellitus. ( Agbaje, IM; Amigues, E; Browne, RA; Green, BD; Hollis, J; Mallidis, C; McClure, N; Migaud, M; Rogers, D, 2009) |
| "Aminocarnitine has a strong hypoglycemic effect in fasted diabetic mice; a single dose (0." | 1.27 | Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines. ( Griffith, OW; Jenkins, DL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kogot-Levin, A | 1 |
| Riahi, Y | 1 |
| Abramovich, I | 1 |
| Mosenzon, O | 1 |
| Agranovich, B | 1 |
| Kadosh, L | 1 |
| Ben-Haroush Schyr, R | 1 |
| Kleiman, D | 1 |
| Hinden, L | 1 |
| Cerasi, E | 1 |
| Ben-Zvi, D | 1 |
| Bernal-Mizrachi, E | 1 |
| Tam, J | 1 |
| Gottlieb, E | 1 |
| Leibowitz, G | 1 |
| Jiang, YP | 1 |
| Yang, JM | 1 |
| Ye, RJ | 1 |
| Liu, N | 1 |
| Zhang, WJ | 1 |
| Ma, L | 1 |
| Zheng, P | 1 |
| Niu, JG | 1 |
| Liu, P | 1 |
| Yu, JQ | 1 |
| Liu, Q | 1 |
| Chiu, A | 1 |
| Wang, LH | 1 |
| An, D | 1 |
| Zhong, M | 1 |
| Smink, AM | 1 |
| de Haan, BJ | 1 |
| de Vos, P | 1 |
| Keane, K | 1 |
| Vegge, A | 1 |
| Chen, EY | 1 |
| Song, W | 1 |
| Liu, WF | 1 |
| Flanders, J | 1 |
| Rescan, C | 1 |
| Grunnet, LG | 1 |
| Wang, X | 1 |
| Ma, M | 1 |
| Huang, B | 1 |
| Hu, X | 1 |
| Hu, J | 1 |
| Chen, Z | 1 |
| Zhao, H | 1 |
| Zahedi, L | 1 |
| Ghourchi Beigi, P | 1 |
| Shafiee, M | 1 |
| Zare, F | 1 |
| Mahdikia, H | 1 |
| Abdouss, M | 1 |
| Abdollahifar, MA | 1 |
| Shokri, B | 1 |
| Xie, J | 1 |
| Lu, Y | 1 |
| Wang, W | 1 |
| Zhu, H | 1 |
| Wang, Z | 1 |
| Cao, Z | 1 |
| Du, J | 1 |
| Shen, L | 1 |
| Tan, Z | 1 |
| Zhang, P | 1 |
| Zhao, X | 1 |
| Xu, Y | 1 |
| Gan, M | 1 |
| Yang, Q | 1 |
| Ma, J | 1 |
| Jiang, A | 1 |
| Tang, G | 1 |
| Jiang, Y | 1 |
| Jin, L | 1 |
| Li, M | 1 |
| Bai, L | 1 |
| Li, X | 1 |
| Wang, J | 1 |
| Zhang, S | 1 |
| Zhu, L | 1 |
| GhavamiNejad, A | 1 |
| Lu, B | 1 |
| Giacca, A | 1 |
| Wu, XY | 1 |
| Kim, YG | 1 |
| Lim, HH | 1 |
| Lee, SH | 1 |
| Shin, MS | 1 |
| Kim, CJ | 1 |
| Yang, HJ | 1 |
| Minkler, PE | 1 |
| Stoll, MS | 1 |
| Ingalls, ST | 1 |
| Kerner, J | 1 |
| Hoppel, CL | 1 |
| Zabrodina, VV | 2 |
| Shreder, ED | 2 |
| Shreder, OV | 2 |
| Durnev, AD | 2 |
| Seredenin, SB | 1 |
| Patterson, AD | 1 |
| Bonzo, JA | 1 |
| Li, F | 1 |
| Krausz, KW | 1 |
| Eichler, GS | 1 |
| Aslam, S | 1 |
| Tigno, X | 1 |
| Weinstein, JN | 1 |
| Hansen, BC | 1 |
| Idle, JR | 1 |
| Gonzalez, FJ | 1 |
| Katayama, K | 1 |
| Sato, T | 1 |
| Arai, T | 1 |
| Amao, H | 1 |
| Ohta, Y | 1 |
| Ozawa, T | 1 |
| Kenyon, PR | 1 |
| Hickson, RE | 1 |
| Tazaki, H | 1 |
| Mallidis, C | 1 |
| Green, BD | 1 |
| Rogers, D | 1 |
| Agbaje, IM | 1 |
| Hollis, J | 1 |
| Migaud, M | 1 |
| Amigues, E | 1 |
| McClure, N | 1 |
| Browne, RA | 1 |
| Tornello, S | 1 |
| Fridman, O | 1 |
| Weisenberg, L | 1 |
| Coirini, H | 1 |
| De Nicola, AF | 1 |
| Duan, RD | 1 |
| Cheng, Y | 1 |
| Erlanson-Albertsson, C | 1 |
| Guder, WG | 1 |
| Beck, FX | 1 |
| Schmolke, M | 1 |
| Goldstein, L | 1 |
| Jenkins, DL | 1 |
| Griffith, OW | 1 |
20 other studies available for betaine and Alloxan Diabetes
| Article | Year |
|---|---|
Mapping the metabolic reprogramming induced by sodium-glucose cotransporter 2 inhibition.
Topics: AMP-Activated Protein Kinases; Animals; Betaine; Diabetes Mellitus, Experimental; Glucose; Methionin | 2023 |
Protective effects of betaine on diabetic induced disruption of the male mice blood-testis barrier by regulating oxidative stress-mediated p38 MAPK pathways.
Topics: Animals; Antioxidants; Betaine; Blood-Testis Barrier; Catalase; Diabetes Mellitus, Experimental; Dis | 2019 |
Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation.
Topics: Alginates; Animals; Betaine; Carbonic Acid; Cell Encapsulation; Cell Proliferation; Diabetes Mellitu | 2019 |
Betaine Alleviates Cognitive Deficits in Diabetic Rats via PI3K/Akt Signaling Pathway Regulation.
Topics: Animals; Behavior, Animal; Betaine; Blood Glucose; Cognition; Cognition Disorders; Cytokines; Diabet | 2020 |
Development of plasma functionalized polypropylene wound dressing for betaine hydrochloride controlled drug delivery on diabetic wounds.
Topics: Animals; Betaine; Diabetes Mellitus, Experimental; Diabetic Foot; Drug Delivery Systems; Rats; Rats, | 2021 |
Simple Protein Modification Using Zwitterionic Polymer to Mitigate the Bioactivity Loss of Conjugated Insulin.
Topics: Animals; Betaine; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Immobilized Proteins | 2017 |
Betaine Supplementation Enhances Lipid Metabolism and Improves Insulin Resistance in Mice Fed a High-Fat Diet.
Topics: 3T3-L1 Cells; Adipocytes, White; Adipogenesis; Adiposity; Animals; Animals, Outbred Strains; Anti-Ob | 2018 |
Glucose regulation by modified boronic acid-sulfobetaine zwitterionic nanogels - a non-hormonal strategy for the potential treatment of hyperglycemia.
Topics: Animals; Betaine; Blood Glucose; Boronic Acids; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2019 |
Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats.
Topics: Animals; Betaine; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypoxia-In | 2015 |
Validated method for the quantification of free and total carnitine, butyrobetaine, and acylcarnitines in biological samples.
Topics: Animals; Betaine; Carnitine; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; | 2015 |
Effect of Afobazole and Betaine on DNA Damage in Placental and Embryonic Tissues of Rats with Experimental Streptozocin Diabetes.
Topics: Animals; Antimutagenic Agents; Benzimidazoles; Betaine; Diabetes Mellitus, Experimental; Diabetes, G | 2015 |
Effect of Afobazole and Betaine on Cognitive Disorders in the Offspring of Rats with Streptozotocin-Induced Diabetes and Their Relationship with DNA Damage.
Topics: Animals; Benzimidazoles; Betaine; Cognition; Cognition Disorders; Comet Assay; Diabetes Mellitus, Ex | 2016 |
Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus.
Topics: Amino Acid Transport Systems, Neutral; Animals; Betaine; Citric Acid; Diabetes Mellitus, Experimenta | 2011 |
Non-targeted analyses of animal plasma: betaine and choline represent the nutritional and metabolic status.
Topics: Animals; Betaine; Cattle; Chickens; Choline; Diabetes Mellitus, Experimental; Female; Male; Mice; Mi | 2013 |
Metabolic profile changes in the testes of mice with streptozotocin-induced type 1 diabetes mellitus.
Topics: Animals; Betaine; Carnitine; Choline; Creatine; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2009 |
Differences in corticosterone binding by regions of the central nervous system in normal and diabetic rats.
Topics: Adrenalectomy; Animals; Betaine; Brain; Cerebral Cortex; Corticosterone; Diabetes Mellitus, Experime | 1981 |
Effect of emeriamine on exocrine and endocrine pancreatic function in normal and diabetic rats.
Topics: Amylases; Animals; Betaine; Blood Glucose; Carnitine; Diabetes Mellitus, Experimental; Female; Hypog | 1992 |
Regulation and localization of organic osmolytes in mammalian kidney.
Topics: Animals; Betaine; Diabetes Insipidus; Diabetes Mellitus, Experimental; Glycerylphosphorylcholine; In | 1990 |
Organic solute profiles and transport in the rat renal medulla.
Topics: Animals; Betaine; Biological Transport; Diabetes Mellitus, Experimental; Glycerylphosphorylcholine; | 1989 |
Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines.
Topics: Acyltransferases; Animals; Betaine; Blood Glucose; Caprylates; Carnitine; Carnitine O-Palmitoyltrans | 1986 |